005

neta:studio_ai:news_show:2026-09-27:005

Stanford researchers described a Virtual Biotech made up of as many as 37,000 AI agents organized across drug-development tasks. The system analyzed large bodies of clinical and biological evidence and generated a lung-cancer treatment hypothesis that could be compared with later trial evidence.